Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

XOKOPHARMA : revenue, balance sheet and financial ratios

XOKOPHARMA is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-PIERRE-D'IRUBE (64990), this company of category PME shows in 2023 a net income positive of 137 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - XOKOPHARMA (SIREN 524036043)
Indicator 2023 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 136 707 € 249 895 € 155 253 € 111 651 € 100 635 € 55 391 € 97 685 €
EBITDA N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2023, XOKOPHARMA generates positive net income of 137 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 98 k€ -> 137 k€.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

136 707 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 14%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 70%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

13.743%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

70.086%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

23.2%

Solvency indicators evolution
XOKOPHARMA

Sector positioning

Debt ratio
13.74 2023
2020
2021
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Excellent -7 pts over 3 years

In 2023, the debt ratio of XOKOPHARMA (13.74) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
70.09% 2023
2020
2021
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Excellent +8 pts over 3 years

In 2023, the financial autonomy of XOKOPHARMA (70.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 146.53. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

146.526

Liquidity indicators evolution
XOKOPHARMA

Sector positioning

Liquidity ratio
146.53 2023
2020
2021
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Average -20 pts over 3 years

In 2023, the liquidity ratio of XOKOPHARMA (146.53) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of XOKOPHARMA in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of XOKOPHARMA is estimated at 1 613 070 € (range 980 985€ - 2 267 615€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
980k€ 1613k€ 2267k€
1 613 070 € Range: 980 985€ - 2 267 615€
NAF 5 année 2023

Valuation method used

Net Income Multiple
136 707 € × 11.8x = 1 613 071 €
Range: 980 986€ - 2 267 616€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare XOKOPHARMA with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about XOKOPHARMA

What is the revenue of XOKOPHARMA ?

The revenue of XOKOPHARMA is not publicly disclosed (confidential accounts filed with INPI).

Is XOKOPHARMA profitable?

Yes, XOKOPHARMA generated a net profit of 137 k€ in 2023.

Where is the headquarters of XOKOPHARMA ?

The headquarters of XOKOPHARMA is located in SAINT-PIERRE-D'IRUBE (64990), in the department Pyrenees-Atlantiques.

Where to find the tax return of XOKOPHARMA ?

The tax return of XOKOPHARMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does XOKOPHARMA operate?

XOKOPHARMA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.